{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:37:49Z","timestamp":1776854269215,"version":"3.51.2"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012769","name":"Neuroscience Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["259867"],"award-info":[{"award-number":["259867"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["Z01-AG000949-02"],"award-info":[{"award-number":["Z01-AG000949-02"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/s1474-4422(13)70036-x","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T14:46:13Z","timestamp":1360766773000},"page":"310-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":453,"title":["Controversies and priorities in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Martin R","family":"Turner","sequence":"first","affiliation":[]},{"given":"Orla","family":"Hardiman","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Benatar","sequence":"additional","affiliation":[]},{"given":"Benjamin R","family":"Brooks","sequence":"additional","affiliation":[]},{"given":"Adriano","family":"Chio","sequence":"additional","affiliation":[]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[]},{"given":"Paul G","family":"Ince","sequence":"additional","affiliation":[]},{"given":"Cindy","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Robert G","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Hiroshi","family":"Mitsumoto","sequence":"additional","affiliation":[]},{"given":"Garth","family":"Nicholson","sequence":"additional","affiliation":[]},{"given":"John","family":"Ravits","sequence":"additional","affiliation":[]},{"given":"Pamela J","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Swash","sequence":"additional","affiliation":[]},{"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[]},{"given":"Bryan J","family":"Traynor","sequence":"additional","affiliation":[]},{"given":"Leonard H","family":"Van den Berg","sequence":"additional","affiliation":[]},{"given":"Jan H","family":"Veldink","sequence":"additional","affiliation":[]},{"given":"Steve","family":"Vucic","sequence":"additional","affiliation":[]},{"given":"Matthew C","family":"Kiernan","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(13)70036-X_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(13)70036-X_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(13)70036-X_bib3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/S1474-4422(13)70036-X_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/S1474-4422(13)70036-X_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"issue":"suppl 1","key":"10.1016\/S1474-4422(13)70036-X_bib6","first-page":"S3","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(13)70036-X_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","article-title":"Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS","volume":"85","author":"Turner","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/S1474-4422(13)70036-X_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/17482968.2010.495158","article-title":"Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)\u2014a 20-year review: can we do better?","volume":"11","author":"Mitchell","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jnnp.74.7.995","article-title":"Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990\u20132002","volume":"74","author":"Turner","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study","volume":"82","author":"Chio","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/S1474-4422(13)70036-X_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneur.57.8.1171","article-title":"Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: what do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.48.1.55","article-title":"Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase","volume":"48","author":"Juneja","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.0b013e3181ed9cde","article-title":"Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations","volume":"75","author":"Baumer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(12)70014-5","article-title":"Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study","volume":"11","author":"Byrne","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1212\/WNL.0b013e3182735d36","article-title":"Extensive genetics of ALS: a population-based study in Italy","volume":"79","author":"Chio","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9ORF72 -linked FTLD and MND\/ALS","volume":"122","author":"Al-Sarraj","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","article-title":"The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study","volume":"83","author":"Phukan","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.2009.204446","article-title":"Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy","volume":"82","author":"Raaphorst","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1017\/S0317167100120803","article-title":"Neuropsychological functioning in PLS: a comparison with ALS","volume":"38","author":"Grace","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/01.wnl.0000200962.94777.71","article-title":"The natural history of primary lateral sclerosis","volume":"66","author":"Gordon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000302187.20239.93","article-title":"The history of progressive muscular atrophy: syndrome or disease?","volume":"70","author":"Visser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archneurol.2009.91","article-title":"A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes","volume":"66","author":"Van den Berg-Vos","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/115.2.495","article-title":"Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria","volume":"115","author":"Pringle","year":"1992","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jnnp.2006.105056","article-title":"Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis","volume":"78","author":"Vucic","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib31","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/brain\/awr178","article-title":"White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis","volume":"134","author":"Iwata","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review","author":"Costa","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/mus.880160810","article-title":"Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons","volume":"16","author":"Chou","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(13)70036-X_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u201cdying-back\u201d phenomenon of motor neurons in ALS","volume":"43","author":"Dadon-Nachum","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mus.880150215","article-title":"Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?","volume":"15","author":"Eisen","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(13)70036-X_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21404","article-title":"Amyotrophic lateral sclerosis\u2014evolutionary and other perspectives","volume":"40","author":"Eisen","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(13)70036-X_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.2010.05888.x","article-title":"The human connectome: a complex network","volume":"1224","author":"Sporns","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib38","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0905267106","article-title":"Correspondence of the brain's functional architecture during activation and rest","volume":"106","author":"Smith","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(13)70036-X_bib39","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/brain\/awr279","article-title":"Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis","volume":"134","author":"Douaud","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib40","doi-asserted-by":"crossref","first-page":"e24239","DOI":"10.1371\/journal.pone.0024239","article-title":"Impaired structural motor connectome in amyotrophic lateral sclerosis","volume":"6","author":"Verstraete","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(13)70036-X_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jnnp-2011-301530","article-title":"Absence of consensus in diagnostic criteria for familial neurodegenerative diseases","volume":"83","author":"Byrne","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib43","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awr248","article-title":"The risk to relatives of patients with sporadic amyotrophic lateral sclerosis","volume":"134","author":"Hanby","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib44","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/brain\/awr296","article-title":"Familial versus sporadic amyotrophic lateral sclerosis\u2014a false dichotomy?","volume":"134","author":"Talbot","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib45","doi-asserted-by":"crossref","first-page":"e48983","DOI":"10.1371\/journal.pone.0048983","article-title":"Genetic overlap between apparently sporadic motor neuron diseases","volume":"7","author":"van Blitterswijk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(13)70036-X_bib46","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.284.13.1664","article-title":"Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22","volume":"284","author":"Hosler","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(13)70036-X_bib47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1474-4422(07)70037-6","article-title":"Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data","volume":"6","author":"Schymick","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(07)70222-3","article-title":"ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study","volume":"6","author":"van Es","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/hmg\/ddm361","article-title":"A genome-wide association study of sporadic ALS in a homogenous Irish population","volume":"17","author":"Cronin","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng.2007.52","article-title":"Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis","volume":"40","author":"van Es","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/hmg\/ddn375","article-title":"Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration","volume":"18","author":"Simpson","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib52","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/hmg\/ddp059","article-title":"A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis","volume":"18","author":"Chi\u00f2","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib53","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1073\/pnas.0812937106","article-title":"Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis","volume":"106","author":"Landers","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(13)70036-X_bib54","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng.442","article-title":"Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis","volume":"41","author":"van Es","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib55","first-page":"2989","article-title":"Association between DPP6 polymorphism and the risk of sporadic amyotrophic lateral sclerosis in Chinese patients","volume":"122","author":"Li","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/S1474-4422(13)70036-X_bib56","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(10)70197-6","article-title":"Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study","volume":"9","author":"Shatunov","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib57","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1474-4422(10)70184-8","article-title":"Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study","volume":"9","author":"Laaksovirta","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib58","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1093\/hmg\/ddr268","article-title":"A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese","volume":"20","author":"Iida","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib59","doi-asserted-by":"crossref","first-page":"e32768","DOI":"10.1371\/journal.pone.0032768","article-title":"A high-density genome-wide association screen of sporadic ALS in US veterans","volume":"7","author":"Kwee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(13)70036-X_bib60","doi-asserted-by":"crossref","first-page":"357.e7","DOI":"10.1016\/j.neurobiolaging.2012.07.017","article-title":"Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1","volume":"34","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(13)70036-X_bib61","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1093\/hmg\/ddm215","article-title":"Genetics of sporadic amyotrophic lateral sclerosis","volume":"16","author":"Schymick","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.59.5.773","article-title":"Premorbid weight, body mass, and varsity athletics in ALS","volume":"59","author":"Scarmeas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.WNL.0000149513.82332.5C","article-title":"Physical activity and the association with sporadic ALS","volume":"64","author":"Veldink","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2011-301161","article-title":"Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study","volume":"83","author":"Turner","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib65","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","article-title":"Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis","volume":"82","author":"Sutedja","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib66","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.0b013e318231530b","article-title":"Family history of neurodegenerative and vascular diseases in ALS: a population-based study","volume":"77","author":"Huisman","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/brain\/awh373","article-title":"Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players","volume":"128","author":"Chio","year":"2005","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/01.WNL.0000148649.17706.D9","article-title":"Prospective study of military service and mortality from ALS","volume":"64","author":"Weisskopf","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib69","first-page":"911","article-title":"Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis","volume":"13","author":"Cheah","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/S1474-4422(13)70036-X_bib70","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1113\/jphysiol.2009.177022","article-title":"Amyotrophic lateral sclerosis and the neuroprotective potential of exercise","volume":"597","author":"Kiernan","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10072-011-0921-9","article-title":"Exercise and amyotrophic lateral sclerosis","volume":"33","author":"de Almeida","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(13)70036-X_bib73","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cortex.2011.07.008","article-title":"What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease","volume":"48","author":"Bak","year":"2012","journal-title":"Cortex"},{"key":"10.1016\/S1474-4422(13)70036-X_bib74","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp.2010.208413","article-title":"Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis","volume":"82","author":"Turner","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib75","article-title":"Reduced cancer incidence in Huntington's disease: record linkage study clue to an evolutionary trade-off?","author":"Turner","year":"2012","journal-title":"Clinical Genet"},{"key":"10.1016\/S1474-4422(13)70036-X_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jnnp.73.2.199","article-title":"Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation","volume":"73","author":"Aggarwal","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib77","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","volume":"131","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib78","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.0b013e318231526a","article-title":"Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS","volume":"77","author":"Carew","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib79","first-page":"635","article-title":"Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability","volume":"82","author":"Vivekananda","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib80","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.0b013e31826e9b1d","article-title":"Presymptomatic studies in ALS: rationale, challenges, and approach","volume":"79","author":"Benatar","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1212\/WNL.7.2.124","article-title":"Collateral regeneration from residual motor nerve fibers in amyotrophic lateral sclerosis","volume":"7","author":"Wohlfart","year":"1957","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.2006.103564","article-title":"Prognosis of amyotrophic lateral sclerosis with respiratory onset","volume":"78","author":"Shoesmith","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib85","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1093\/brain\/aws144","article-title":"Young-onset amyotrophic lateral sclerosis: historical and other observations","volume":"135","author":"Turner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2011.00042","article-title":"Brainstem: neglected locus in neurodegenerative diseases","volume":"2","author":"Grinberg","year":"2011","journal-title":"Front Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib87","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/jnnp.2006.112078","article-title":"Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis","volume":"78","author":"Vucic","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib88","article-title":"Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality","author":"Bede","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib89","doi-asserted-by":"crossref","first-page":"15775","DOI":"10.1523\/JNEUROSCI.3539-11.2011","article-title":"Rich-club organization of the human connectome","volume":"31","author":"van den Heuvel","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib90","doi-asserted-by":"crossref","first-page":"e13664","DOI":"10.1371\/journal.pone.0013664","article-title":"Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study","volume":"5","author":"Verstraete","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S1474-4422(13)70036-X_bib91","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cell.2011.10.011","article-title":"The seeds of neurodegeneration: prion-like spreading in ALS","volume":"147","author":"Polymenidou","year":"2011","journal-title":"Cell"},{"key":"10.1016\/S1474-4422(13)70036-X_bib92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp-2011-301826","article-title":"Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?","volume":"83","author":"Kanouchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jnnp-2012-303992","article-title":"How does ALS spread between neurones in the CNS?","volume":"84","author":"Swash","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib94","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/17482968.2011.580849","article-title":"Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS","volume":"12","author":"Sabatelli","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib95","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/17482960903420140","article-title":"Pattern of spread and prognosis in lower limb-onset ALS","volume":"11","author":"Turner","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib96","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/jnnp-2011-300141","article-title":"Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis","volume":"82","author":"Fujimura-Kiyono","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(13)70036-X_bib97","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-1331.2011.03616.x","article-title":"Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis","volume":"19","author":"Gargiulo-Monachelli","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib98","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","article-title":"Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction","volume":"118","author":"Haverkamp","year":"1995","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/146608202317576499","article-title":"Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis","volume":"3","author":"Turner","year":"2002","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/S1474-4422(13)70036-X_bib100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(13)70036-X_bib101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/17482968.2011.551940","article-title":"Isolated bulbar phenotype of amyotrophic lateral sclerosis","volume":"12","author":"Burrell","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib102","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/17482960903358865","article-title":"Toward more efficient clinical trials for amyotrophic lateral sclerosis","volume":"11","author":"Cudkowicz","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib103","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/bmm.12.26","article-title":"Neuroimaging in amyotrophic lateral sclerosis","volume":"6","author":"Turner","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/S1474-4422(13)70036-X_bib104","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis","volume":"8","author":"Turner","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrneurol.2011.151","article-title":"Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations","volume":"7","author":"Bowser","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/S1474-4422(13)70036-X_bib107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(13)70036-X_bib108","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00415-010-5609-1","article-title":"Progression in ALS is not linear but is curvilinear","volume":"257","author":"Gordon","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib109","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/nm.2579","article-title":"The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis","volume":"17","author":"Cudkowicz","year":"2011","journal-title":"Nat Med"},{"issue":"suppl 1","key":"10.1016\/S1474-4422(13)70036-X_bib110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/17434470410020067","article-title":"The neurophysiological index in ALS","volume":"5","author":"Swash","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/S1474-4422(13)70036-X_bib111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/17482968.2010.531742","article-title":"Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models","volume":"12","author":"Cheah","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17482960701292837","article-title":"Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS\/MND: report on the 142nd ENMC international workshop","volume":"8","author":"Ludolph","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(13)70036-X_bib115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/S1474-4422(13)70036-X_bib116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00401-012-1058-5","article-title":"Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity","volume":"125","author":"Brockington","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(13)70036-X_bib117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0896-6273(00)81199-X","article-title":"C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway","volume":"26","author":"Sawin","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/S1474-4422(13)70036-X_bib118","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","article-title":"Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy","volume":"100","author":"Kraemer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(13)70036-X_bib119","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nbd.2005.03.017","article-title":"Progressive neurodegeneration in C. elegans model of tauopathy","volume":"20","author":"Miyasaka","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S1474-4422(13)70036-X_bib120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1469-7580.2011.01459.x","article-title":"Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?","volume":"220","author":"Thomson","year":"2012","journal-title":"J Anat"},{"key":"10.1016\/S1474-4422(13)70036-X_bib121","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1073\/pnas.1202922109","article-title":"Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability","volume":"109","author":"Bilican","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(13)70036-X_bib122","doi-asserted-by":"crossref","first-page":"42984","DOI":"10.1074\/jbc.M112.417600","article-title":"Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis","volume":"287","author":"Tashiro","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(13)70036-X_bib123","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147444221370036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147444221370036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T10:15:27Z","timestamp":1761473727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147444221370036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S147444221370036X"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(13)70036-x","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies and priorities in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(13)70036-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}